Insiders the Biggest Winners as CervoMed Inc.'s (NASDAQ:CRVO) Market Cap Rises to US$151m
Insiders the Biggest Winners as CervoMed Inc.'s (NASDAQ:CRVO) Market Cap Rises to US$151m
Key Insights
主要见解
- Insiders appear to have a vested interest in CervoMed's growth, as seen by their sizeable ownership
- 53% of the business is held by the top 6 shareholders
- 21% of CervoMed is held by Institutions
- 内部人士似乎对CervoMed的增长有着既得利益,这可以从他们持有的大量股权中看出。
- 前6名股东持有该业务的53%。
- 21%的CervoMed由机构持有。
If you want to know who really controls CervoMed Inc. (NASDAQ:CRVO), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are individual insiders with 35% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
如果你想知道谁真正控制着CervoMed Inc. (NASDAQ:CRVO) ,那么你需要看看它的股东名册组成。持有35%股权的个人内部人士是持有最大股份的群体。换句话说,这个群体面临着最大的上行潜力(或下行风险)。
Clearly, insiders benefitted the most after the company's market cap rose by US$58m last week.
显然,内部人士在公司市值上涨5800万美元后获益最多。
In the chart below, we zoom in on the different ownership groups of CervoMed.
下面的图表展示了CervoMed的不同持股群体。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240818/0-5a1d7f8705a32efee13a6a5f4a6f2c34-0-a21aa02c586d7d1c73841ff3461c4b10.png/big)
What Does The Institutional Ownership Tell Us About CervoMed?
机构投资者持股情况告诉我们关于CervoMed的什么?我们可以看到CervoMed确实有机构投资者,并且他们持有公司股份的一部分。这意味着那些机构的分析师已经研究过该股票,并且他们喜欢它。但就像其他任何人一样,他们可能会犯错。如果多个机构同时改变对一只股票的看法,你可能会看到股价快速下跌。因此,值得看一下CervoMed下面的收益历史。当然,未来才是真正重要的。
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。
We can see that CervoMed does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at CervoMed's earnings history below. Of course, the future is what really matters.
纳斯达克:CRVO收益和营业收入增长2024年8月18日。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240818/0-5a1d7f8705a32efee13a6a5f4a6f2c34-1-55b74e9b3291f0a778cd52ba20dd37dc.png/big)
It would appear that 7.8% of CervoMed shares are controlled by hedge funds. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Our data shows that Joshua Boger is the largest shareholder with 13% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 9.9% and 8.9%, of the shares outstanding, respectively. John Alam, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.
CervoMed的内部所有权我们的信息表明,内部人士在CervoMed Inc.保持着相当大的持股。内部人员在这家15,100万美元的企业中持股5300万美元。这可能表明创始人仍然拥有很多股份。你可以 点击此处查看他们是否一直在买卖。
We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.
我们还观察到,前6大股东持有超过一半的股份登记簿,有一些较小的股东来平衡较大股东的利益。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
虽然研究一个公司的机构持股数据是有意义的,但研究分析师预期增长也是有意义的,因为很多分析师都有关注这些股票,因此可以很容易地了解预期增长。
Insider Ownership Of CervoMed
一般公众,通常是个人投资者,持有CervoMed的27%股权。虽然这一持股规模可观,但如果该决策与其他大股东不一致,可能不足以改变公司政策。
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间是不同的。我们的数据反映了个别内部人员,至少捕捉到了董事会成员。公司管理业务,但首席执行官即使是董事会成员也必须向董事会负责。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多数人认为内部所有权是积极的,因为它可以表示董事会与其他股东的利益相一致。但是,在某些场合下,这个团体的权力过于集中。
Our information suggests that insiders maintain a significant holding in CervoMed Inc.. Insiders have a US$53m stake in this US$151m business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.
股权投资公司持有CervoMed的9.9%股权。这表明他们在关键政策决策中可能发挥影响力。有些投资者可能会因此受到鼓舞,因为私募股权有时能够鼓励制定能够帮助市场看到公司价值的战略。此外,这些持有者也可能在上市后退出投资。
General Public Ownership
一般大众所有权
The general public, who are usually individual investors, hold a 27% stake in CervoMed. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
我发现看一家公司的股权结构非常有趣。但是,为了真正获得洞察,我们需要考虑其他信息。以风险为例-CervoMed有4个警告信号(其中有2个不应被忽视),我们认为你应该了解。
Private Equity Ownership
股权投资公司持有8.8%的股份,有能力参与塑造以价值创造为重点的公司策略。一些投资者可能会因此而受到鼓舞,因为股权投资公司有时可以鼓励市场看到公司的价值,从而采取有益的策略。另外,那些持有者可能在将其上市后退出投资。
Private equity firms hold a 9.9% stake in CervoMed. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.
内部所有权CervoMed our information suggests that insiders maintain a significant holding in CervoMed Inc.. Insiders have a US$5300万 stake in this US$15100万 business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - CervoMed has 4 warning signs (and 2 which shouldn't be ignored) we think you should know about.
我发现看一家公司的股权结构非常有趣。但是,为了真正获得洞察,我们需要考虑其他信息。以风险为例-CervoMed有4个警告信号(其中有2个不应被忽视),我们认为你应该了解。
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最终,决定该业务所有者将获得多大利益的是未来而非过去。因此,我们认为最好查看此免费报告,以了解分析师是否预测更光明的未来。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。